Litcius/Paper detail

Loss of Myo19 increases metastasis by enhancing microenvironmental ROS gradient and chemotaxis

Xiaoyu Ren, Peng Shi, Jing Su, Tonghua Wei, Jiayi Li, Yiping Hu, Congying Wu

2024EMBO Reports18 citationsDOIOpen Access PDF

Abstract

Abstract Tumor metastasis involves cells migrating directionally in response to external chemical signals. Reactive oxygen species (ROS) in the form of H 2 O 2 has been demonstrated as a chemoattractant for neutrophils but its spatial characteristics in tumor microenvironment and potential role in tumor cell dissemination remain unknown. Here we investigate the spatial ROS distribution in 3D tumor spheroids and identify a ROS concentration gradient in spheroid periphery, which projects into a H 2 O 2 gradient in tumor microenvironment. We further reveal the role of H 2 O 2 gradient to induce chemotaxis of tumor cells by activating Src and subsequently inhibiting RhoA. Finally, we observe that the absence of mitochondria cristae remodeling proteins including the mitochondria-localized actin motor Myosin 19 (Myo19) enhances ROS gradient and promotes tumor dissemination. Myo19 downregulation is seen in many tumors, and Myo19 expression is negatively associated with tumor metastasis in vivo. Together, our study reveals the chemoattractant role of tumor microenvironmental ROS and implies the potential impact of mitochondria cristae disorganization on tumor invasion and metastasis.

Topics & Concepts

ChemotaxisTumor microenvironmentCell biologyMetastasisRHOABiologyMitochondrionDownregulation and upregulationReactive oxygen speciesTumor progressionCell migrationCancer researchChemistryCellSignal transductionCancerTumor cellsReceptorBiochemistryGeneticsGeneMitochondrial Function and PathologyNanoplatforms for cancer theranosticsCancer, Hypoxia, and Metabolism
Loss of Myo19 increases metastasis by enhancing microenvironmental ROS gradient and chemotaxis | Litcius